Sero-prevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia

详细信息    查看全文

• 作者：Letebrhan Weldemhret ; Tsehaye Asmelash ; Rashmi Belodu…
• 关键词：HBV ; HBsAg sero ; prevalence ; Associated risk factors
• 刊名：AIDS Research and Therapy
• 出版年：2016
• 出版时间：December 2016
• 年：2016
• 卷：13
• 期：1
• 全文大小：817 KB
• 参考文献：1.Liver EAftSot, Française SdPIdL. Short statement of the first European consensus conference on the treatment of chronic hepatitis C and B in HIV co-infected patients. Médecine et maladies infectieuses. 2005;35(3):109–20.CrossRef
  2.Barth RE, Huijgen Q, Taljaard J, Hoepelman AI. Hepatitis B/C and HIV in Sub-Saharan Africa: an association between highly prevalent infectious diseases. a systematic review and meta-analysis. Int J Infect Dis. 2010;14(12):e1024–31.CrossRef PubMed
  3.Lincoln D, Petoumenos K, Dore GJ. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med. 2003;4(3):241–9.CrossRef PubMed
  4.Annie Luetkemeyer. Hepatitis B and HIV coinfection. HIV in site knowledge base chapter. Oct 2010.
  5.Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand. Hepatology. 2008;48(4):1062–9.CrossRef PubMed
  6.Ott J, Stevens G, Groeger J, Wiersma S. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg sero-prevalence and endemicity. Vaccine. 2012;30(12):2212–9.CrossRef PubMed
  7.Soriano V, Puoti M, Bonacini M, Brook G, Cargnel A, et al. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV–HBV international panel. AIDS. 2005;19(3):221–40.PubMed
  8.Chun HM, Roediger MP, Hullsiek KH, Thio CL, Agan BK, et al. Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters. J Infect Dis. 2012;205(2):185–93.PubMedCentral CrossRef PubMed
  9.Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97–107.CrossRef PubMed
  10.Sulkowski MS. Management of hepatic complications in HIV-infected persons. J Infect Dis. 2008;197(Supplement 3):S279–93.CrossRef PubMed
  11.Lacombe K, Rockstroh J. HIV and viral hepatitis coinfections: advances and challenges. Gut. 2012;61(Suppl 1):i47–58.CrossRef PubMed
  12.Zenebe Y, Mulu W, Yimer M, Abera B. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2014;14(1):118.PubMedCentral CrossRef PubMed
  13.Dessie A, Abera B, Wale F. Sero-prevalence of major blood-borne infections among blood donars at Felege Hiwot referral hospital, Northwest Ethiopia. Ethiop J Health Dev. 2007;21(1):68–9.CrossRef
  14.Wondimeneh Y, Alem M, Asfaw F, Belyhun Y. HBV and HCV sero-prevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest Ethiopia. Virol J. 2013;10(1):1–8.CrossRef
  15.Balew M, Moges F, Yismaw G, Unakal C. Assessment of hepatitis B virus and hepatitis C virus infections and associated risk factors in HIV infected patients at Debretabor hospital, South Gondar, Northwest Ethiopia. Asian Pac J Trop Dis. 2014;4(1):1–7.PubMedCentral CrossRef
  16.Leech NL, Barrett KC, Morgan GA. SPSS for intermediate statistics: use and interpretation. California: Psychol Press; 2005.
  17.Hosmer DW Jr, Lemeshow S. Applied logistic regression. New York: Wiley; 2004.
  18.Gelaw B, Mengitsu Y. The prevalence of HBV, HCV and malaria parasites among blood donor in Amhara and Tigray regional states. Ethiop J Health Dev. 2008;22(1):3–7.CrossRef
  19.Ive P, MacLeod W, Mkumla N, Orrell C, Jentsch U, et al. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial. PloS ONE. 2013;8(12):e74900.PubMedCentral CrossRef PubMed
  20.Tsuchiya N, Pathipvanich P, Rojanawiwat A, Wichukchinda N, Koga I, et al. Chronic hepatitis B and C co-infection increased all-cause mortality in HAART-naive HIV patients in northern Thailand. Epidemiol Infect. 2013;141(09):1840–8.PubMedCentral CrossRef PubMed
  21.Alo M, Alhassan H, Saidu A, Ugah U, Umar F. CD 4 + T cell count in patients concomitantly infected with HIV and hepatitis B virus in Sokoto State, Nigeria. Am J Epidemiol Infect Dis. 2013;1(3):24–6.
  22.Chen X, He J-M, Ding L-S, Zhang G-Q, Zou X-B, et al. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China. Arch Virol. 2013;158(9):1889–94.CrossRef PubMed
  23.Baha W, Foullous A, Dersi N, They-they TP, Nourichafi N, et al. Prevalence and risk factors of hepatitis B and C virus infections among the general population and blood donors in Morocco. BMC Public Health. 2013;13(1):50.PubMedCentral CrossRef PubMed
  24.Khan F, Shams S, Qureshi ID, Israr M, Khan H, et al. Hepatitis B virus infection among different sex and age groups in Pakistani Punjab. Virol J. 2011;8(1):225–9.PubMedCentral CrossRef PubMed
  25.Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507–39.CrossRef PubMed
  26.Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJ, Revill P, et al. Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection. J Virol. 2009;83(15):7649–58.PubMedCentral CrossRef PubMed
  27.Ikeh CK, Oboma Y, Ikeh PE. Patterns of CD4 + cells and liver enzymes and their correlation with prevalence of HBV and HCV among HIV positive individuals at Orlu Hospital Counseling and Testing Unit, Imo state, South-East Nigeria. Int J Curr Microbiol Appl Sci. 2014;3(4):296–303.
  28.Van Bommel F, Wunsche T, Mauss S, Reinke P, Schurmann D, et al. Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection. Hepatology. 2004;40(6):1421–5.CrossRef PubMed
  29.Harania RS, Karuru J, Nelson M, Stebbing J. HIV, hepatitis B and hepatitis C coinfection in Kenya. AIDS. 2008;22(10):1221–2.CrossRef PubMed
  30.Isaakidis P, Mansoor H, Zachariah R, Da Silva EA, Varghese B, et al. Treatment outcomes in a cohort of patients with chronic hepatitis B and human immunodeficiency virus co-infection in Mumbai, India. Int Health. 2012;4(4):239–45.CrossRef PubMed
  31.Keith A. Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows. Conference on Retroviruses and Opportunistic Infections (CROI 2015).
  32.Erena AN, Tefera TB. Prevalence of hepatitis B surface antigen (HBsAg) and its risk factors among individuals visiting Goba General Hospital, South East Ethiopia, 2012. BMC Res Notes. 2014;7(1):833.PubMedCentral CrossRef PubMed
  
• 作者单位：Letebrhan Weldemhret (1)
  Tsehaye Asmelash (2)
  Rashmi Belodu (2)
  Dawit Gebreegziabiher (2)
  
  1. Medical Microbiology Laboratory, Mekelle Hospital, Mekelle, Ethiopia
  2. Department of Medical Microbiology and Immunology, College of Health Sciences, Mekelle University, Mekelle, Ethiopia
  
• 刊物主题：Infectious Diseases; Virology;
• 出版者：BioMed Central
• ISSN：1742-6405

文摘

Background Because of the shared mean of transmission, hepatitis B virus (HBV) is one of an important cause of co-morbidity and mortality in peoples living with HIV/AIDS. Hence, the aim of this study was to determine the sero-prevalence of HBV infection and associated risk factors in HIV/AIDS positive individuals attending ART clinic at Mekelle hospital, Mekelle, Northern Ethiopia.